APOA1 and diabetes mellitus: In a meta-analysis of patients with or without diabetes treated with statins, an increase in HDL-C levels after treatment had no significant cardiovascular benefit, whereas an increase in ApoA1 resulted in a substantial reduction in cardiovascular events [40].